课题基金 / 基金详情

Rifampin to reduce elevated levels of blood and urine calcium in patients with inactivating mutations in the CYP24A1 gene

Rifampin to reduce elevated levels of blood and urine calcium in patients with inactivating mutations in the CYP24A1 gene
利福平可降低 CYP24A1 基因失活突变患者升高的血钙和尿钙水平
批准号：
350582
负责人：
Sochett Etienne B
金额：
$4.6万
依托单位：
Hospital for Sick Children (Toronto)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2016
资助国家：
加拿大
项目状态：
已结题
起止时间：
2016-05-01 至 2018-05-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=350582&lang=en
关键词：
Calcium Isotope Absorption Studies Children With Hypercalcemia Caused By Cyp24a1 Mutations Liquid Chromatography-Ms Of Vitamin D Metabolites Phase 1 Proof Of Principle Trial Repurposing Rifampin For Children With Hypercalcemia Sequencing Of Cyp24a1

项目摘要

项目成果

相关文献

中文摘要
翻译
高血钙水平在儿童中并不常见，但很重要，因为它们会使儿童生病，从长远来看，可能会导致肾结石。最近，一种分解维生素D活性形式的基因的变化被发现在
英文摘要
High serum calcium levels are uncommon in children but important because they make the child ill and in the long-term can result in kidney stones. Recently, a change in one of the genes that breaks down the active form of vitamin D has been discovered in
期刊论文(0)
专著(0)
科研奖励(0)
会议论文